Markets:

Overview

News

Currencies

International

Treasuries

Praxis Precision Medicines, Inc. - Common Stock (NQ:PRAX)

304.33 +35.38 (+13.15%)

Streaming Delayed Price Updated: 1:50 PM EST, Dec 29, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Praxis Precision Medicines, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Praxis Stock Surges On FDA Breakthrough Status For Essential Tremor Drug ↗

Today 12:21 EST

Praxis Precision Medicines Inc (NASDAQ: PRAX) stock rose after FDA granted BTD for ulixacaltamide to treat essential tremor.

Via Benzinga

Traders are paying attention to the gapping stocks in Monday's session. ↗

Today 10:30 EST

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday.

Via Chartmill

Why Did Praxis Precision Stock Surge 12% Pre-Market Today? ↗

Today 9:20 EST

The Breakthrough Therapy Designation designation for ulixacaltamide was granted after positive topline results from the Essential3 program, which included two Phase 3 studies.

Via Stocktwits

What's going on in today's session ↗

December 05, 2025

Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

Praxis Precision Medicines Stock Drops After Culper Research Reveals Short Position ↗

November 20, 2025

Via Stocktwits

Why Did Praxis Precision Medicines Stock Surge 69% In Pre-Market Today? ↗

October 16, 2025

Via Stocktwits

Top movers analysis in the middle of the day on 2025-12-05: top gainers and losers in today's session. ↗

December 05, 2025

Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.

Via Chartmill

The market is filled with gapping stocks in Friday's session. ↗

December 05, 2025

Let's have a look at what is happening on the US markets on Friday. Below you can find the gap up and gap down stocks in today's session.

Via Chartmill

What's going on in today's pre-market session ↗

December 05, 2025

Before the opening bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

Why Did PRAX Stock Rocket 24% Pre-Market Today? ↗

December 05, 2025

The Data Monitoring Committee (DMC) recommended stopping the EMBOLD study ahead of schedule after the interim analysis demonstrated strong positive outcomes.

Via Stocktwits

Praxis Precision Medicines Stock Surges 25% In Friday Pre-Market Trading— What's Going On? ↗

December 05, 2025

Praxis Precision Medicines Inc. (NASDAQ: PRAX) shares surged 24.81% in pre-market trading on Friday, climbing to $237.10— what's going on?

Via Benzinga

Nasdaq, S&P 500 Futures Set For Firm Open Ahead Of PCE Inflation Data: Why NFLX, SMX, SOFI, IOT Are On Traders' Radar ↗

December 05, 2025

Retail sentiment, however, remains cautious, with SPY and QQQ flashing bearish on Stocktwits.

Via Stocktwits

Curious about the stocks that are showing activity after the closing bell on Thursday? ↗

December 04, 2025

As the regular session of the US market concludes on Thursday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

Short Seller Alleges Praxis Precision's Potential $3 Billion Drug 'A House Of Cards' ↗

November 20, 2025

Short seller challenges Praxis' Phase 3 ulixacaltamide data, alleging major flaws that could undermine FDA approval and the company's valuation.

Via Benzinga

Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally

November 07, 2025

The biotech sector is currently experiencing a robust rally, a significant turnaround from a period of subdued performance. This resurgence is primarily fueled by a wave of promising drug trial results...

Via MarketMinute

Topics Artificial Intelligence Intellectual Property

Kimberly-Clark, Vertex And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

November 03, 2025

Via Benzinga

Meet the Biotech Stock That Just Jumped 251% Higher ↗

October 26, 2025

Find out what sent this typically overlooked stock through the roof.

Via The Motley Fool

Revolution Medicines, Disc Medicine, American Express And Other Big Stocks Moving Higher On Friday ↗

October 17, 2025

Via Benzinga

Why CSX Shares Are Trading Higher By Over 4%; Here Are 20 Stocks Moving Premarket ↗

October 17, 2025

Via Benzinga

Praxis Precision Stock Extends Rally Premarket As Wall Street Turns Hyper-Bullish After Essential Tremor Trial Win ↗

October 17, 2025

Wall Street boosted the stock’s price targets after the company’s late-stage trial for its essential tremor drug, ulixacaltamide, delivered strong efficacy and safety data.

Via Stocktwits

Topics Death

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 16, 2025

Via Benzinga

Dow Dips Over 100 Points; US Crude Oil Inventories Surge ↗

October 16, 2025

Via Benzinga

Topics Stocks

The 'Groundbreaking' Results That Sent Praxis Precision Medicines Up 200% ↗

October 16, 2025

The company is working on a treatment for essential tremor. Positive results shocked investors following a negative readout in February.

Via Investor's Business Daily

Enerpac Tool Group Posts Upbeat Results, Joins Praxis Precision Medicines, J B Hunt, Salesforce And Other Big Stocks Moving Higher On Thursday ↗

October 16, 2025

Via Benzinga

Dow Surges Over 100 Points; Charles Schwab Posts Upbeat Earnings ↗

October 16, 2025

Via Benzinga

Topics Stocks

Stay updated with the stocks that are on the move in today's pre-market session. ↗

October 16, 2025

The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 16, 2025

Via Benzinga

Praxis Precision Medicines Stock Doubles - Here's Why ↗

October 16, 2025

Praxis stock jumps after Phase 3 trials show ulixacaltamide significantly improves essential tremor symptoms and meets key efficacy endpoints.

Via Benzinga

Praxis' Epilepsy Treatment Shows Promise With Decreased Seizures ↗

August 04, 2025

Praxis Precision Medicines stock fluctuated after reporting mixed results for their drug vormatrigine in treating focal onset seizures.

Via Benzinga

Praxis (PRAX) Q2 Loss Widens 90% ↗

August 04, 2025

Via The Motley Fool

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.